Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2023 Earnings Call Transcript

Collegium Pharmaceutical, Inc. misses on earnings expectations. Reported EPS is $0.82 EPS, expectations were $1.33.

Keep Reading →